Arthroscopy News and Research

RSS

Arthroscopy (also called arthroscopic surgery) is a minimally invasive surgical procedure in which an examination and sometimes treatment of damage of the interior of a joint is performed using an arthroscope, a type of endoscope that is inserted into the joint through a small incision. Arthroscopic procedures can be performed either to evaluate or to treat many orthopaedic conditions including torn floating cartilage, torn surface cartilage, ACL reconstruction, and trimming damaged cartilage.

Smith & Nephew launches DYONICS RF System to remove soft tissue during arthroscopic surgery

Smith & Nephew's Endoscopy Division today announced the launch of the DYONICS™ RF System, which incorporates a compact generator with a family of probes for aggressively removing defects and smoothing soft tissue during arthroscopic surgery.

24 Feb 2010

International experts to develop comprehensive guidelines for Negative Pressure Wound Therapy

An international group of experts on Negative Pressure Wound Therapy (NPWT) will assemble this week to develop a comprehensive, evidence-based consensus on the use of NPWT. The International NPWT Expert Panel is drafting recommendations for a range of NPWT indications and techniques that reflect the body of NPWT published clinical evidence.

3 Feb 2010

Gentag signs license agreement to develop and commercialize post surgery wireless skin patch

Gentag, Inc. and The CORE Institute® are pleased to announce the signing of a license agreement to develop and commercialize a disposable wireless skin patch to allow patients to self monitor themselves in the comfort of their homes after orthopedic surgery in hospitals through the use of cell phones

2 Feb 2010

Symmetry Medical signs supply agreement with Indiana-based bio-science company

Symmetry Medical Inc., a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today it has entered into an exclusive five-year supply agreement with OrthoPediatrics Corp., a Warsaw, Indiana-based bio-science company that develops, designs and distributes anatomically appropriate orthopedic implants and solutions for pediatric and small stature patients.

27 Jan 2010

MaMayo Clinic experts available to discuss health issues and concerns related to Olympic Games

Mayo Clinic's medical experts are sources of in-depth expertise and commentary about health issues and background related to the Olympic Games and Olympians. Below is a sampling of Mayo Clinic experts available to discuss numerous topics related to the Olympic Games, including concussions, performance enhancing drugs, sports psychology, joint injuries, etc. Mayo has satellite capability for broadcast requests.

21 Jan 2010

Smith & Nephew makes available more than $2M in implants and surgical instruments for Haiti earthquake victims

Medical device maker Smith & Nephew's Orthopaedics business is making available this week more than $2 million in implants and surgical instruments for use by orthopedic surgeons in the treatment of survivors of last week's earthquake in Haiti.

21 Jan 2010

Biomet reports second quarter financial results for fiscal 2010

Biomet, Inc. net sales increased 8% during the second fiscal quarter ended November 30, 2009, to $695.6 million from $642.8 million during the second quarter of fiscal year 2009. On a constant currency basis, net sales increased 5% during the second quarter of fiscal 2010.

6 Jan 2010

Smith & Nephew adds PELNAC dermal replacement wound product to its portfolio

Smith & Nephew (LSE: SN) Advanced Wound Management division, announces the agreement to partner with Gunze Limited, Japan and exclusively distribute PELNAC dermal replacement in Japan, South Africa, Australia and New Zealand.

24 Dec 2009

NUCRYST Pharmaceuticals announces the closing of previously announced sale

NUCRYST Pharmaceuticals Corp. ("Nucryst") is pleased to announce the closing of the previously announced sale of substantially all of the assets of Nucryst pursuant to an asset purchase agreement dated November 10, 2009, as amended, among Nucryst, NUCRYST Pharmaceuticals Inc., Smith & Nephew Inc. and Smith & Nephew (Overseas) Limited (the "Asset Sale").

23 Dec 2009

Smith & Nephew acquires property, manufacturing and operation assets of Nucryst Pharmaceuticals

The Advanced Wound Management division of Smith & Nephew plc (LSE: SN; NYSE: SNN), announced today that its affiliates have completed the acquisition of substantially all of the assets of Nucryst Pharmaceuticals Corp. ("Nucryst").

22 Dec 2009

Symmetry Medical to increase operational efficiency and drive annualized cost savings by restructuring

Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today a restructuring that includes a facility consolidation and other staff reductions designed to increase operational efficiency and drive annualized cost savings.

19 Dec 2009

National medical societies launch multi-state advertising campaign to oppose current health care bill

Today, a group of national medical societies launched a multi-state advertising campaign in opposition to H.R. 3590, the Patient Protection and Affordable Care Act, currently under consideration by the U.S. Senate and making its way towards a final vote in the coming days.

17 Dec 2009

Smith & Nephew signs a technology development contract with the U.S. Department of Defense

Smith & Nephew Orthopaedics Division is pleased to announce the signing of a technology development contract with the United States Department of Defense that may lead to the creation of a fracture fixation system intended to revolutionize the treatment of the limbs of soldiers who sustain battlefield injuries.

20 Nov 2009

OA panel develops a consensus of the optimal exogenous HA treatment using BioRestorative Profiling

A panel of osteoarthritis (OA) key opinion leaders has developed a consensus of the optimal exogenous hyaluronic acid (HA) treatment. This consensus was achieved by utilizing what the experts referred to as BioRestorative(TM) Profiling. This profiling examines HAs on the basis of their mimicking the body's natural HA.

19 Nov 2009

CONMED Linvatec produces the smallest Biocomposite Interference screw for fixation of ACL and PCL grafts

CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of new sizes of its Matryx™ Biocomposite Interference Screw. These new screws represent the latest advance in biocomposite material technology that allows CONMED Linvatec to produce the smallest Biocomposite Interference screw available on the market today for primary fixation of ACL and PCL grafts.

17 Nov 2009

Smith & Nephew launches new operative hysteroscopy device

Smith & Nephew's Endoscopy Division announced the launch of the TRUCLEAR(TM) System, an operative hysteroscopy device, which is now widely available in the United States.

17 Nov 2009

Bullseye Anatomic Cruciate Reconstruction System released

CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of the Bullseye™ Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee.

16 Nov 2009

Single reimbursement code for NPWT devices: Smith & Nephew endorses decision

The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc, applauded the federal government's decision last week to maintain the current, single reimbursement code for negative pressure wound therapy (NPWT) devices.

9 Nov 2009

Study demonstrates that both gauze and foam interfaces provide comparable healing rates in NPWT systems

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew Plc, highlighted the results of a multi-center study which demonstrates that gauze-based Negative Pressure Wound Therapy (NPWT) achieves many of the common treatment goals defined for foam-based NPWT systems. These goals include a reduction in wound dimension, exudate, and improvement in granulation tissue.

24 Oct 2009

Smith & Nephew to present comprehensive portfolio of advanced wound management products at Annual Clinical Symposium

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew Plc (LSE: SN; NYSE: SNN), announced today that clinicians will present a total of 20 clinical posters featuring its Negative Pressure Wound Therapy (NPWT) Systems and ALLEVYN(TM) AG, ALLEVYN AG Gentle, ACTICOAT(TM) and IODOSORB(TM) advanced wound dressings during the 24th Annual Clinical Symposium on Advances in Skin and Wound Care's poster session. The poster session opens at 10:30am CT on October 23, 2009.

22 Oct 2009